Ductal closure in infants under 6 kg including premature infants using Amplatzer duct occluder type two additional sizes: a single-centre experience in South Africa.

Background: This is a report on percutaneous closure of patent ductus arteriosus (PDA) using Amplatzer Duct Occluder type two additional sizes (ADO II AS) in patients under 6 kg.

Methods: Prospective data were collected and a review of Patients' records was conducted. Demographics, and angiographic and clinical outcomes are reported in this article.

Patent ductus arteriosus closure using Occlutech Duct Occluder, experience in Port Elizabeth, South Africa.

Background: Percutaneous closure of patent ductus arteriosus (PDA) has become standard therapy. Experience with the Occlutech® Duct Occluder is limited.

Methods: Data regarding ductal closure using Occlutech® Duct Occluder were reviewed and prospectively collected.

Clinical presentation and outcomes of patients with acute rheumatic fever and rheumatic heart disease seen at a tertiary hospital setting in Port Elizabeth, South Africa.

Background: The incidence of acute rheumatic fever (ARF) and rheumatic heart disease (RHD) has waned in Western countries, however that is not the situation in developing nations.

Methods: Records were reviewed of patients from the Eastern Cape municipal districts who presented to the Paediatric Cardiology Unit with ARF and RHD from January 2008 to August 2015.

Results: Total of 56 patients with ARF/RHD was reviewed.